Search

everythinglearnresearchcommunity

for

Search:↓

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

Nanoparticles added to natural materials like cellulose and collagen can improve cell growth and wound healing, but more testing is needed to ensure they're safe and effective.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Nanofat shows promise for facial rejuvenation and treating skin issues but needs more research for long-term safety.

Topical calcitriol-analogs can reduce hair loss caused by chemotherapy.

Colchicine might help treat different skin diseases, but more research is needed to confirm its effectiveness and safe dosage.

Acne can't be cured but can be managed with treatments like benzoyl peroxide and diet changes; it's costly and can lead to scarring and mental health issues.

Alpinetin helps grow hair by turning on hair stem cells and is safe for use.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Human fetal placental stromal cell injections speed up healing and improve skin and hair recovery after radiation damage.

The nervous system helps control stem cell behavior and immune responses, affecting tissue repair and maintenance.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Maxillariinae orchids contain 62 compounds with potential health benefits, including treating skin conditions and diseases like cancer and diabetes.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

Sweet syndrome can be the only sign of hairy cell leukemia relapse.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Injectables can feminize or masculinize a transgender person's face, but more research is needed for best practices.

In Poland, people search more for certain skin conditions depending on the season, and despite more STD infections, searches for them have decreased, suggesting a need for better sexual education.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Aromatase inhibitor therapy for breast cancer increases the risk of hair loss and thinning.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Spironolactone may help enlarge a small breast linked to Becker's nevus.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Scalp cooling effectively prevents severe hair loss in breast cancer patients treated with docetaxel and is safe.

The document suggests that blocking sweat glands with antiperspirants might allow skin-generated hormones to be absorbed, possibly increasing breast and prostate cancer risk.

A specific hair diffraction pattern may indicate breast cancer if tested with the correct method.